Dr. Erik J. Stratman, MD

Dr. Stratman practices at Marshfield Center Ambulatory Surgical Center - HOPD in Marshfield, Wisconsin.

Dr. Stratman's NPI, 1780799213, was assigned on August 21, 2006. Dr. Stratman holds Wisconsin license 41500.

Dr. Stratman's primary practice is Marshfield Center Ambulatory Surgical Center - HOPD, at 1000 N Oak Ave, Marshfield, WI 54449.

Dr. Stratman's primary practice is Marshfield Center Ambulatory Surgical Center - HOPD in Marshfield, Wisconsin. Dr. Stratman is also affiliated with Marshfield Medical Center - Marshfield. The medical group on file is Marshfield Clinic Health System. Dmand AI also links Dr. Stratman to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Stratman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stratman practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Stratman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Stratman is licensed in Wisconsin.

CMS data shows 804 Medicare services from Dr. Stratman across 13 procedure codes in 2024, for 343 Medicare patients. Medicare paid $41,795 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 343 Medicare patients who saw Dr. Stratman in 2024. The largest group is 65 to 74, with 155 patients. 69% of them have high blood pressure, and 67% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stratman's median patient age at 74, with 47% women.

In 2024, Dr. Stratman wrote 380 Medicare Part D claims for 158 patients. 91% of them were for generic drugs. CMS names the drug for 289 of them, across 12 drugs with 11 or more claims each, at $68,395 in total drug cost. In 2023, CMS named 337 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Stratman for performance year 2024, reported as part of a group. Dr. Stratman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of melanoma (skin cancer) excision by Dr. Stratman, more than 80% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Stratman, published from 2010 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Dermatology, Internship and Residency and Skin Neoplasms. Dr. Stratman has published most often in JAMA Dermatol. Dr. Stratman's most frequent co-authors are Stanley Joseph Miller, MD, Thomas Dag Horn, MD and Deirdre Anne Stolmeier, MD.

CMS Open Payments shows 1 general payment to Dr. Stratman from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $80.